Edgewell Personal Care Company EPC
27.93 USD -0.54 (-1.90%)
At closeNov 3, 2026, 4:22 PM EST
27.93 0.00 0.00%
After hours · Nov 3, 4:22 PM ET
27.82 Day range 28.67
15.73 52-week range 29.95
- YTD
- +63.81%
- 1 year
- +45.47%
Analyst view
Consensus: buy
Buy
Price target (mean) 31.50 +12.8% upside
Now 27.93
- Target (low)
- 29.00
- Target (mean)
- 31.50
- Target (high)
- 35.00
Ratings (0m) 7 3 buy · 4 hold · 0 sell
- Strong buy1
- Buy2
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.77052 | 0.758 – 0.79 | 0.68 | +13.3% | 479.80M | -10.7% | 7 |
| Next quarter | 0.01117 | -0.09 – 0.13 | -0.16 | +107.0% | 424.43M | -12.8% | 6 |
| Current year | 1.93 | 1.91 – 1.95 | 2.52 | -23.6% | 1.99B | -10.4% | 7 |
| Next year | 1.98 | 1.82 – 2.04 | 1.93 | +2.8% | 2.02B | +1.4% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 7, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 6, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 21, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 16, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 7, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 8, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 10, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 10, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jan 5, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 18, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 14, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Nov 14, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 14, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Sep 25, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 6, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 6, 2025 | UBS | Maintained | Neutral | Neutral |
| Aug 6, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 6, 2025 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| Jul 15, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| May 8, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| May 8, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 17, 2025 | UBS | Maintained | Neutral | Neutral |
| Apr 11, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 11, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 11, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
